What Is a Biotech Company and What Services Does It Provide?

A biotech company applies biological systems, living organisms, or molecular biology techniques to develop products and services. The term covers a wide range: some companies discover and develop drugs, some supply research reagents and custom manufacturing, and some do both. GenScript, for example, describes itself as a biotech company focused exclusively on early drug discovery and development services, offering Bio-Reagent, Bio-Assay, Lead Optimization, and Antibody Drug Development. Use this article to recognize what a biotech company does and to evaluate one by its specialization and service portfolio.

How a biotech company differs from pharma and general life-science suppliers

The three categories overlap, but their center of gravity differs:

A biotech company often sits upstream of pharma: it generates the molecules, data, or candidates that later move into clinical development. Some biotech companies also commercialize their own products, so the boundary is not absolute. The practical distinction is where the company spends most of its effort — discovery and enabling services versus large-scale clinical and commercial operations.

Typical service areas

Biotech service providers commonly organize their offerings around the molecule types and workflows researchers need. GenScript's portfolio illustrates the pattern:

• Gene synthesis — building custom DNA sequences for research or production.
• Peptide synthesis — producing custom peptides for assays, screening, or development work.
• Protein production — expressing and purifying proteins for study or downstream use.
• Custom antibody services — generating antibodies against a target of interest.
• Cell line services — developing cell lines for experiments or production.

These services share a common logic: they supply a customized biological material that a lab would otherwise need to build in-house. That makes them relevant to academic groups, small biotechs without full internal capacity, and larger organizations that want to outsource specific steps.

Where early drug discovery and development fits

Early drug discovery is the stage before clinical testing: identifying targets, generating candidate molecules, and testing them in the lab. A biotech company that positions itself here bundles the services above into a discovery workflow — for instance, synthesizing genes and proteins to study a target, screening candidates, optimizing leads, and developing antibodies.

GenScript frames its offering this way: Bio-Reagent, Bio-Assay, Lead Optimization, and Antibody Drug Development. The value of a bundled portfolio is fewer handoffs between vendors; the trade-off is that you should confirm each step is genuinely in-house rather than subcontracted, and that the company's specialization matches your project stage.

What to check when evaluating a biotech company

• Specialization — does the company focus on your stage (discovery, assay development, optimization) or spread across many unrelated areas?
• Service portfolio coverage — can it handle the full sequence of steps you need, or only one?
• Fit of service types — confirm the specific services you require, such as gene synthesis or custom antibody generation, are listed rather than assumed.
• Terms and conditions — review purchase terms before committing; pricing and ordering details are governed by the company's own terms, so check them directly rather than assuming standard rates.
• Evidence of capability — look for described workflows and deliverables for each service, not just service names.

Common misconceptions

• "A biotech company makes drugs." Many do not; service and reagent providers enable drug discovery without selling a medicine.
• "All biotech companies are interchangeable." A gene synthesis provider and a lead optimization provider solve different problems; match the company to your task.
• "Services are one-size-fits-all." Custom synthesis and antibody work are project-specific, so scope and terms vary.
• "Biotech means clinical-stage." Early discovery services sit well before clinical trials.

The practical takeaway: define your stage and the materials you need, then check whether a given biotech company's specialization and listed services cover that work end to end.